Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The flavoured powder is a prenatal calcium supplement delivery vehicle developed by **The Hospital for Sick Children** (SickKids) in collaboration with the **International Centre for Diarrhoeal Disease Research, Bangladesh**. It contains elemental calcium derived from calcium carbonate and is formulated with a suspension agent to be mixed with water and consumed with a meal. This formulation was designed to improve adherence and ease of swallowing for pregnant women, particularly those experiencing nausea, as part of an initiative to address calcium deficiency and reduce the risk of preeclampsia in low-resource settings. In clinical evaluations (NCT01676636), it was compared against traditional tablets, chewable tablets, and unflavoured powders to assess preference, acceptability, and palatability. The study found that the flavoured powder had a significantly lower probability of selection (12%) compared to traditional tablets (62%).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on flavoured powder-The Hospital for Sick Children.